These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31598104)

  • 1. Evaluating the Use of Octreotide for Acquired Chylothorax in Pediatric Critically Ill Patients Following Cardiac Surgery.
    Bui A; Long CJ; Breitzka RL; Wolovits JS
    J Pediatr Pharmacol Ther; 2019; 24(5):406-415. PubMed ID: 31598104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease.
    Paramés F; Freitas I; Fragata J; Trigo C; Pinto MF
    Rev Port Cardiol; 2009; 28(7-8):799-807. PubMed ID: 19894659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of prolonged drainage of chylothorax after cardiac surgery: single centre study.
    Sersar SI
    Pediatr Surg Int; 2011 Aug; 27(8):811-5. PubMed ID: 21660449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide for congenital and acquired chylothorax in newborns: A systematic review.
    Bellini C; Cabano R; De Angelis LC; Bellini T; Calevo MG; Gandullia P; Ramenghi LA
    J Paediatr Child Health; 2018 Aug; 54(8):840-847. PubMed ID: 29602276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective.
    Aljazairi AS; Bhuiyan TA; Alwadai AH; Almehizia RA
    Asian Cardiovasc Thorac Ann; 2017 Jan; 25(1):6-12. PubMed ID: 27920229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylothorax in children after congenital heart surgery.
    Chan SY; Lau W; Wong WH; Cheng LC; Chau AK; Cheung YF
    Ann Thorac Surg; 2006 Nov; 82(5):1650-6. PubMed ID: 17062221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide for chylous effusions in congenital diaphragmatic hernia.
    Landis MW; Butler D; Lim FY; Keswani S; Frischer J; Haberman B; Kingma PS
    J Pediatr Surg; 2013 Nov; 48(11):2226-9. PubMed ID: 24210190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide for management of chylothorax following bidirectional Glenn in a three-month-old infant.
    Wright SB; Mainwaring RD
    J Card Surg; 2009; 24(2):216-8. PubMed ID: 19267835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study.
    Zhang C; Zhang H; Wu W; Liu D; Yang D; Zhang M; Lu C
    Medicine (Baltimore); 2019 Jul; 98(29):e16599. PubMed ID: 31335742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery.
    Nath DS; Savla J; Khemani RG; Nussbaum DP; Greene CL; Wells WJ
    Ann Thorac Surg; 2009 Jul; 88(1):246-51; discussion 251-2. PubMed ID: 19559234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.
    Yin R; Zhang R; Wang J; Yuan L; Hu L; Jiang S; Chen C; Cao Y
    Medicine (Baltimore); 2017 Jul; 96(29):e7594. PubMed ID: 28723800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative chylothorax after cardiothoracic surgery in children.
    Chan EH; Russell JL; Williams WG; Van Arsdell GS; Coles JG; McCrindle BW
    Ann Thorac Surg; 2005 Nov; 80(5):1864-70. PubMed ID: 16242470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide for the treatment of chylothorax in neonates.
    Das A; Shah PS
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006388. PubMed ID: 20824848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide as a therapeutic option for management of chylothorax.
    Al-Zubairy SA; Al-Jazairi AS
    Ann Pharmacother; 2003 May; 37(5):679-82. PubMed ID: 12708946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review.
    Jenkinson AC; McGuinness J; Prendiville T
    Pediatr Cardiol; 2023 Feb; 44(2):297-305. PubMed ID: 36255468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Use of Octreotide Acetate in the Management of Refractory Chylothorax Following Surgical Treatment for Lung Cancer].
    Kawakami T; Ishida I; Sugawara T; Oura H
    Kyobu Geka; 2016 Jun; 69(6):429-32. PubMed ID: 27246125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with single ventricle anatomy may respond better to octreotide therapy for chylothorax after congenital heart surgery.
    White SC; Seckeler MD; McCulloch MA; Buck ML; Hoke TR; Haizlip JA
    J Card Surg; 2014 Mar; 29(2):259-64. PubMed ID: 24354723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database.
    Mery CM; Moffett BS; Khan MS; Zhang W; Guzmán-Pruneda FA; Fraser CD; Cabrera AG
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):678-86.e1; discussion 685-6. PubMed ID: 24246545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide Use in Neonates: A Case Series.
    Zaki SA; Krishnamurthy MB; Malhotra A
    Drugs R D; 2018 Sep; 18(3):191-198. PubMed ID: 29948779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.